Approved Study Database

Ref. No. Scientific Title Principal investigator
2016.623 Pharmacoepidemiology and pharmacoeconomics of oral anticoagulation therapy in Hong Kong Dr. YAN Bryan Ping Yen
2017.003 Implantation of the Venus P-ValveTM in the Pulmonic Position in Patients with Native Outflow Tracts Prof. YAN Bryan Ping Yen
甄秉言
2016.630 Renal Artery Sympathetic Denervation by Catheter Ablation after Pulmonary Vein Isolation (PVI) for Persistent Atrial Fibrillation Prof. YAN Bryan Ping Yen
甄秉言
2014.258 A Clinical Outcomes Study to Compare the Incidence of Major Adverse Cardiovascular Events in Subjects Presenting with Acute Coronary Syndrome Treated with Losmapimod Compared to Placebo Prof. YAN Bryan Ping Yen
2016.490 Development of personalized medicine using Prenetics iGenes pharmacogenomic panel to predict individual responses to cardiovascular drugs Prof. YAN Bryan Ping Yen
甄秉言
2016.319 Investigation on the novel noninvasive sensors and algorithms for validating cuffless continuous blood pressure measurement. Prof. YAN Bryan Ping Yen
甄秉言
2016.509 Hong Kong Percutaneous Coronary Intervention Registry Prof. YAN Bryan Ping Yen
甄秉言
2016.550 Validation of Camera-based Measurement of Finger & Facial Photoplethysmographic Signal for Heart Rate and Arrhythmias Detection Prof. YAN Bryan Ping Yen
甄秉言
2016.531 Prospective Observational study of Lipid Management in Non-US, Non-Western European Patients Who Have A Recent Acute Coronary Syndrome Event Dr. YAN Bryan Ping Yen
甄秉言
2017.316 Electrical Activation Mapping Guided Tailor Made Approach for Cardiac Resynchronization Therapy Prof. YAN Bryan Ping Yen
2014.381 Multinational Abluminal Sirolimus Coated BiO-Engineered StenT – The MASCOT Post Marketing Registry Dr. YAN Bryan Ping Yen
2018.068 A nurse-coordinated integrated care model to support decision-making and self-care in patients with atrial fibrillation: A randomized controlled trial Prof. YAN Bryan Ping Yen
2016.265 The Effect of CYP2C19 Genetic Variants on Clinical Outcomes in Post-Angioplasty Patients Treated with Clopidogrel Prof. YAN Bryan Ping Yen
甄秉言
2018.215 Electrical Activation Mapping Guided Cardiac Resynchronization Therapy for Nonresponders Prof. YAN Bryan Ping Yen
2018.299 Lipid management status of patients with ischemic stroke (IS) in Hong Kong Prof. YAN Bryan Ping Yen
2019.653 In-Depth Analyses of 12-lead ECG P-wave Indices Using Machine Learning to Predict Atrial Fibrillation and Cardiovascular Events Prof. YAN Bryan Ping Yen
甄秉言
2018.304 Achievement of cardiovascular risk factor goals and target levels in patients at very-high and high cardiovascular risk in Hong Kong Prof. YAN Bryan Ping Yen
甄秉言
2019.357 Prolonged Ambulatory Heart Rate Variability Monitoring to Predict Major Adverse Cardiac Events in High-risk Patients with Cardiovascular Diseases Prof. YAN Bryan Ping Yen
甄秉言
2020.448 Rationale and Design of DAbigatran for Stroke PreVention In Atrial Fibrillation in MoDerate or Severe Mitral Stenosis (DAVID-MS): A Randomized, Open-label study Prof. YAN Bryan Ping Yen
甄秉言教授
2018.214 XIENCE 28 Global Study Prof. YAN Bryan Ping Yen
甄秉言
2018.382 ILUMIEN IV: OPTIMAL PCI OPtical Coherence Tomography (OCT) Guided Coronary Stent IMplantation Compared to Angiography: a Multicenter Randomized TriaL in PCI Prof. YAN Bryan Ping Yen
甄秉言
2018.393 Validation of a cuffless blood pressure device for 24-hours ambulatory blood pressure monitoring Prof. YAN Bryan Ping Yen
甄秉言
2020.154 BIOFLOW-DAPT: BIOTRONIK – A Prospective, Randomized, Multi-center Study to Assess the SaFety of the Orsiro Mission Stent compared to the ResoLute Onyx Stent in Subjects at High Risk for Bleeding in combination With 1-month Dual AntiPlatelet Therapy Prof. YAN Bryan Ping Yen
甄秉言
2019.346 HD Mapping Observational Study Prof. YAN Bryan Ping Yen
甄秉言
2019.571 Gaps In Awareness of Peripheral Arterial Disease in Hong Kong: A Cross Sectional Study Prof. YAN Bryan Ping Yen
甄秉言
2020.082 A Non-randomized, Clinical Registry of the DynamX Novolimus Eluting Coronary Bioadaptor System in the Treatment of Patients with De Novo Native Coronary Artery Lesions Prof. YAN Bryan Ping Yen
甄秉言教授
2020.080 A randomized double-blind, placebo-controlled, multicenter trial assessing the impact of lipoprotein (a) lowering with TQJ230 on major cardiovascular events in patients with established cardiovascular disease Prof. YAN Bryan Ping Yen
甄秉言教授
2018.442 A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Efficacy and Safety of CSL112 in Subjects with Acute Coronary Syndrome Prof. YAN Bryan Ping Yen
甄秉言
2019.004 Multi-center cross-sectional epidemiological study to characterize the prevalence and distribution of lipoprotein(a) levels among patients with established cardiovascular disease Prof. YAN Bryan Ping Yen
甄秉言教授
2019.021 Activation Pattern and Acute Hemodynamics of His and Left Bundle Pacing Prof. YAN Bryan Ping Yen
2013.082 Physiologic-Guided Endovascular Revascularization for the Treatment of Atherosclerotic Erectile Dysfunction in Chinese Patients with Suboptimal Response to Pharmacotherapy: A Pilot Study Prof. YAN Bryan Ping Yen
2009.543 Patients at High Cardiovascular Risk Lack Awareness of the Importance of Risk Factor Modification and the Dire Consequences Associated with Peripheral Artery Disease : A cross sectional cohort study Prof. YAN Bryan Ping Yen
2009.542 Impact of unrecognized peripheral arterial disease and additional prognostic value of ankle-brachial index to risk-stratify patients at high cardiovascular risk undergoing coronary angiography or intervention Prof. YAN Bryan Ping Yen
2010.123 Cardiovascular Risk Profile & Long-term Clinical Outcomes of Patients with Peripheral Arterial Disease in Hong Kong Prof. YAN Bryan Ping Yen
2013.607 Dyslipidemia International Study II (DYSIS II) Dr Yan Bryan Ping Yen
2017.695 Validation of a new non-invasive oscillometric device for capillary blood pressure measurement Dr. YAN Bryan
甄秉言
2015.538 A multicenter study to evaluate safety and tolerability in patients with chronic heart failure and reduced ejection fraction from PARADIGM-HF receiving open label LCZ696 Prof. YAN Bryan
甄秉言教授
2013.351 Effect of Heparin on Radial Artery Occlusion After Transradial Artery Catheterization for Coronary Angiography. Professor YAN Bryan
2011.053 Efficacy, Safety and cost-effectiveness of anti-proliferative treatment of coronary arteries with catheter-based delivery of fluid paclitaxel after bare-metal stenting to reduce restenosis in high-risk patients: A multicenter randomized controlled study Prof Yan Bryan
2009.041 Efficacy, Safety and Cost-Effectiveness of Drug-eluting Stents in “Real World” Hong Kong Cardiology Practice Dr. YAN Bryan
2009.167 Chinese Translation and Validation of the Walking Impairment Questionnaire in Patients with Peripheral Arterial Disease Prof. YAN Bryan
2010.595 Hong Kong Cardiovascular Health Survey: Awareness & Knowledge of Cardiovascular Risk & Cardiovascular Risk Reduction Behaviour Prof Yan Bryan
2010.003 Novel care pathway for managing patients with acute urinary retention in the emergency medicine ward: a retrospective study Ms YAM Shuk Fong Estella
2013.563 Left ventricular mass and clinical characteristics of persistent masked hypertension in Hong Kong youth - a community cohort study Dr Yam Man Ching
2024.049 Review of efficacy and safety of MEK inhibitor for treatment of neurofibromatosis Type 1 (NF1)-associated plexiform neurofibroma (PN) in Hong Kong Dr Yam Kwan Ming
任君明
2016.521 Evaluation of the association of electroencephalogram (EEG) patterns with mortality in patients with altered mental state Dr. YAM Kwan Ming
任君明
2011.009 A Cross-sectional Study on Specific Upper Limb Muscle Activities and Fatigue Pattern after simulated Game with Electromyography and Synchronized Video Capture for Boccia Athletes Ms Yam Kit Yee
2012.387 The impact of sleep deprivation on paediatric resident clinical performance in Hong Kong Dr YAM Karen Kwan Ming
2019.310 Normal range of superior mesenteric artery on computerized tomography in young Chinese population and its correlation with retroperitoneal adipose tissue Dr. YAM Kai Ho
2019.698 Incidence, clinical presentation, treatment modalities, and long term outcomes of Retinoblastoma in Hong Kong: Hong Kong Retinoblastoma Registry Dr. YAM Jason Cheuk Sing
任卓昇

Page 18 of 262.